 |
|
Replacing Alteplase with Tenecteplase: Is the Time Ripe?
Nishita Singh, Bijoy K. Menon, Adam A. Dmytriw, Robert W. Regenhardt, Joshua A. Hirsch, Aravind Ganesh
J Stroke. 2023;25(1):72-80. Published online 2023 Jan 31 DOI: https://doi.org/10.5853/jos.2022.02880
|
|
Citations to this article as recorded by
 Informed consent practices for acute stroke therapy: principles, challenges and emerging opportunities
Amir Mbonde, Michael J. Young, Adam A. Dmytriw, Quentin J. Moyer, Joshua A. Hirsch, Thabele M. Leslie-Mazwi, Natalia S. Rost, Aman B. Patel, Robert W. Regenhardt
Journal of Neurology.2024; 271(1): 188. CrossRef Platelet glycoprotein VI inhibition: a promising therapeutic avenue in acute ischaemic stroke
Aravind Ganesh
The Lancet Neurology.2024; 23(2): 125. CrossRef Time to Treatment With Intravenous Thrombolysis Before Thrombectomy and Functional Outcomes in Acute Ischemic Stroke
Johannes Kaesmacher, Fabiano Cavalcante, Manon Kappelhof, Kilian M. Treurniet, Leon Rinkel, Jianmin Liu, Bernard Yan, Wenjie Zi, Kazumi Kimura, Omer F. Eker, Yongwei Zhang, Eike I. Piechowiak, Wim van Zwam, Sheng Liu, Daniel Strbian, Maarten Uyttenboogaar
JAMA.2024; 331(9): 764. CrossRef A Randomized Controlled Trial of Tenecteplase Versus Standard of Care for Minor Ischemic Stroke with Proven Occlusion (TEMPO-2): Rational and design of a multicenter, randomized open-label clinical trial
Nishita Singh, Carol C Kenney, Ken S Butcher, Brian Buck, Philip A Barber, Thalia S Field, Philip M Choi, Amy YX Yu, Timothy Kleinig, Ramana Appireddy, Carlos A Molina, Keith W Muir, Michael D Hill, Shelagh B Coutts
International Journal of Stroke.2024; 19(7): 817. CrossRef Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial
Shelagh B Coutts, Sandeep Ankolekar, Ramana Appireddy, Juan F Arenillas, Zarina Assis, Peter Bailey, Philip A Barber, Rodrigo Bazan, Brian H Buck, Ken S Butcher, Marie-Christine Camden, Bruce C V Campbell, Leanne K Casaubon, Luciana Catanese, Kausik Chatt
The Lancet.2024; 403(10444): 2597. CrossRef Impact and determinants of door in–door out time for stroke thrombectomy transfers in a large hub-and-spoke network
Rashid A. Ahmed, James R. Withers, Joyce A. McIntyre, Thabele M. Leslie-Mazwi, Alvin S. Das, Adam A. Dmytriw, Joshua A. Hirsch, James D. Rabinov, Omer Doron, Christopher J. Stapleton, Aman B. Patel, Aneesh B. Singhal, Natalia S. Rost, Robert W. Regenhardt
Interventional Neuroradiology.2024;[Epub] CrossRef Worldwide Survey on Approach to Thrombolysis in Acute Ischemic Stroke With Large Vessel Occlusion
Nishita Singh, Nima Kashani, Alonso G. Zea Vera, Aleksander Tkach, Aravind Ganesh
Neurology Clinical Practice.2024;[Epub] CrossRef “Intraosseous administration of tenecteplase for thrombolysis of an acute ischemic stroke”
JinJoo Chung, Jonathan Bundy, Sameera Khan, Aaron Hunt, Seth Carroll, Aisha Ali, Neelofer Shafi, Eljim Tesoro
Journal of Stroke and Cerebrovascular Diseases.2024; 33(9): 107850. CrossRef Grand challenges in pediatric stroke
Natalie Ullman, Daniel J. Licht
Frontiers in Stroke.2023;[Epub] CrossRef A comprehensive review of stroke-related signaling pathways and treatment in western medicine and traditional Chinese medicine
Binhao Chen, Weifeng Jin
Frontiers in Neuroscience.2023;[Epub] CrossRef Tenecteplase vs. Alteplase for Intravenous Thrombolytic Therapy of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
Ziyi Shen, Nana Bao, Ming Tang, Yang Yang, Jia Li, Wei Liu, Guohui Jiang
Neurology and Therapy.2023; 12(5): 1553. CrossRef Efficacy and safety of tenecteplase in comparison to alteplase in acute ischemic stroke: A systematic review and meta-analysis of randomized controlled trials
Hassan K. Salamatullah, Bader Bashrahil, Abdulaziz M. Alghamdi, Faisal S. Alsharm, Osama A. Alkulli, Ziyad Alzahrani, Ahmed Alkhiri, Saeed Alghamdi, Seraj Makkawi
Clinical Neurology and Neurosurgery.2023; 233: 107961. CrossRef
|